Quarterly report · Q3

Period2022-01-21 → 2022-10-20
Filed2022-12-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥124.6bn2022-01-21 → 2022-10-20Cons.Net sales
Revenue¥162.6bn2021-01-21 → 2022-01-20Cons.Net sales (5-year summary)
Revenue¥124.7bn2021-01-21 → 2021-10-20Cons.Net sales
Operating income¥2.3bn2022-01-21 → 2022-10-20Cons.Operating income
Operating income¥5.3bn2021-01-21 → 2021-10-20Cons.Operating income
Ordinary income¥2.6bn2022-01-21 → 2022-10-20Cons.Ordinary income
Ordinary income¥5.7bn2021-01-21 → 2022-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.0bn2021-01-21 → 2021-10-20Cons.Ordinary income
Profit before tax¥2.9bn2022-01-21 → 2022-10-20Cons.Income before income taxes
Profit before tax¥6.0bn2021-01-21 → 2021-10-20Cons.Income before income taxes
Net income (owners)¥736m2022-01-21 → 2022-10-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2021-01-21 → 2022-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.9bn2021-01-21 → 2021-10-20Cons.Profit loss attributable to owners of parent
Net income¥725m2022-01-21 → 2022-10-20Cons.Profit loss
Net income¥3.9bn2021-01-21 → 2021-10-20Cons.Profit loss
Total assets¥167.8bnat 2022-10-20Cons.Assets
Total assets¥159.0bnat 2022-01-20Cons.Assets
Total assets¥168.8bnat 2021-10-20Cons.Total assets (5-year summary)
Total liabilities¥83.7bnat 2022-10-20Cons.Liabilities
Total liabilities¥75.7bnat 2022-01-20Cons.Liabilities
Net assets / equity¥84.1bnat 2022-10-20Cons.Net assets
Net assets / equity¥83.3bnat 2022-01-20Cons.Net assets
Net assets / equity¥86.5bnat 2021-10-20Cons.Net assets (5-year summary)
Cash and deposits¥28.9bnat 2022-10-20Cons.Cash and deposits
Cash and deposits¥27.6bnat 2022-01-20Cons.Cash and deposits
EPS (basic)¥46.992022-01-21 → 2022-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥102.452022-07-21 → 2022-10-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥254.22021-01-21 → 2022-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥250.152021-01-21 → 2021-10-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥136.762021-07-21 → 2021-10-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio49.9%at 2022-10-20Cons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2022-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-10-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-10-20−¥521m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-10-20−¥1.0bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥83.6bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥83.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥24m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥2.8bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-10-20−¥380m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥16.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥6m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥1.3bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥15.5bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-10-20−¥752m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-10-20¥9.7bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-10-20¥9.2bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-10-20¥490m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-10-20¥377m
—segment totalrevenue2022-01-21 → 2022-10-20¥125.2bn
—segment totalrevenue external2022-01-21 → 2022-10-20¥124.6bn
—segment totalrevenue intersegment2022-01-21 → 2022-10-20¥521m
—segment totalsegment profit2022-01-21 → 2022-10-20¥3.3bn
Reconciling Itemsreconcilingrevenue2021-01-21 → 2021-10-20−¥463m
Reconciling Itemsreconcilingrevenue intersegment2021-01-21 → 2021-10-20−¥463m
Reconciling Itemsreconcilingsegment profit2021-01-21 → 2021-10-20−¥1.1bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥89.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥89.5bn
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2021-01-21 → 2021-10-20¥37m
jpcrp040300-q3r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-10-20¥5.9bn
jpcrp040300-q3r_E00424-000Dy Do Pharmareportable segmentsegment profit2021-01-21 → 2021-10-20−¥463m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥17.4bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥17.3bn
jpcrp040300-q3r_E00424-000Food Businessreportable segmentrevenue intersegment2021-01-21 → 2021-10-20¥15m
jpcrp040300-q3r_E00424-000Food Businessreportable segmentsegment profit2021-01-21 → 2021-10-20¥1.3bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥9.7bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥9.7bn
jpcrp040300-q3r_E00424-000International Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-10-20−¥384m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2021-01-21 → 2021-10-20¥8.5bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2021-01-21 → 2021-10-20¥8.1bn
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2021-01-21 → 2021-10-20¥409m
jpcrp040300-q3r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2021-01-21 → 2021-10-20¥71m
—segment totalrevenue2021-01-21 → 2021-10-20¥125.1bn
—segment totalrevenue external2021-01-21 → 2021-10-20¥124.7bn
—segment totalrevenue intersegment2021-01-21 → 2021-10-20¥463m
—segment totalsegment profit2021-01-21 → 2021-10-20¥6.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 391
ItemContextValueUnit
Loss on liquidation of subsidiaries and affiliates general elCurrentYTDDuration51000000JPY
Extraordinary lossPrior1YTDDuration20000000JPY
Extraordinary lossCurrentYTDDuration118000000JPY
Income before income taxesPrior1YTDDuration6012000000JPY
Income before income taxesCurrentYTDDuration2941000000JPY
Income taxesPrior1YTDDuration2157000000JPY
Income taxesCurrentYTDDuration2215000000JPY
Profit lossPrior1YTDDuration3854000000JPY
Profit lossCurrentYTDDuration725000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-54000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-10000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration3909000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration736000000JPY
Profit lossPrior1YTDDuration3854000000JPY
Profit lossCurrentYTDDuration725000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration2481000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-2670000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration284000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration915000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration-697000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration5397000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-41000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-156000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration1000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration0JPY
Other comprehensive incomePrior1YTDDuration2027000000JPY
Other comprehensive incomeCurrentYTDDuration3486000000JPY
Comprehensive incomePrior1YTDDuration5882000000JPY
Comprehensive incomeCurrentYTDDuration4211000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration5966000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration4220000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-83000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-8000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember89478000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember9723000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember8122000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember17334000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember-JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember124658000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration124658000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember37000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00424-000InternationalBeverageBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember409000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00424-000FoodBusinessReportableSegmentsMember15000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00424-000DyDoPharmaReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember463000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-463000000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00424-000DomesticBeverageBusinessReportableSegmentsMember89516000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-01-20pass rounding
balance sheet identityconsolidated 2022-10-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-01-20pass
statement vs summary · net assetsconsolidated 2022-10-20pass
statement vs summary · net income attributable to parentconsolidated 2021-01-21/2021-10-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-10-20pass
statement vs summary · revenueconsolidated 2021-01-21/2021-10-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-10-20pass
statement vs summary · total assetsconsolidated 2022-01-20pass
statement vs summary · total assetsconsolidated 2022-10-20pass